Our observations showed that, once inside the cancer cells, Artemisinin-mediated blockage of FoxM1 trans-activation results in downregulation of major transcriptional targets of FoxM1, such as Plk1, cyclinB1, Skp2 and Aurora B kinase. This evidence concerns the gene SKP2 and cancer.